TY - JOUR
T1 - Activation-induced cell death drives profound lung CD4+ T-cell depletion in HIV-associated chronic obstructive pulmonary disease
AU - Popescu, Iulia
AU - Drummond, M. Bradley
AU - Gama, Lucio
AU - Coon, Tiffany
AU - Merlo, Christian A.
AU - Wise, Robert A.
AU - Clements, Janice E.
AU - Kirk, Gregory D.
AU - McDyer, John F.
N1 - Publisher Copyright:
Copyright © 2014 by the American Thoracic Society.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Rationale: As overall survival improves, individuals with HIV infection become susceptible to other chronic diseases, including accelerated chronic obstructive pulmonary disease (COPD). Objectives: To determine whether individuals with HIV-associated COPDexhibit dysregulated lung mucosal T-cell immunity compared with control subjects. Methods: Using flow cytometry, we evaluated peripheral blood and lung mucosal T-cell immunity in 14 HIV+COPD+, 13 HIV+COPD-, and 7 HIV-COPD+ individuals. Measurements and Main Results: HIV+COPD+ individuals demonstrated profound CD4+ T-cell depletion with reduced CD4/CD8 T-cell ratios in bronchoalveolar lavage-derived lung mononuclear cells, not observed in peripheral blood mononuclear cells, and diminished CD4+ T cell absolute numbers, compared with control subjects. Furthermore, HIV+COPD+ individuals demonstrated decreased pulmonary HIV-specific and staphylococcal enterotoxin B-reactive CD4+ memory responses, including loss of multifunctionality, compared with HIV+COPD- control subjects. In contrast, lung mucosal HIV-specific CD8+ T-cell responseswere preserved. LungCD4+ T cells from HIV+COPD+ individuals expressed increased surface Fas death receptor (CD95) and programmed death-1, but similar bronchoalveolar lavage viral loads as control subjects. However, programmed death-1 expression inversely correlated with HIV-specific lung CD4+IFN-γ+ T-cell responses, suggesting functional exhaustion. Moreover, lung CD41 T cells from HIV+COPD+ patients demonstrated increased basal and HIV antigen-induced expression of the early apoptosis marker annexin V compared with control subjects, which was significantly attenuated with anti-Fas blockade. Lastly, lung mucosal, but not blood, CD4+/CD8+ ratios from HIV+ patients significantly correlated with the FEV+, but not in HIV-COPD+ patients. Conclusions: Together, our results provide evidence for profound lung mucosal CD4+ T-cell depletion via a Fas-dependent activationinduced cell death mechanism, along with impaired HIV-specific CD4+ immunity as immunologic features of HIV-associated COPD.
AB - Rationale: As overall survival improves, individuals with HIV infection become susceptible to other chronic diseases, including accelerated chronic obstructive pulmonary disease (COPD). Objectives: To determine whether individuals with HIV-associated COPDexhibit dysregulated lung mucosal T-cell immunity compared with control subjects. Methods: Using flow cytometry, we evaluated peripheral blood and lung mucosal T-cell immunity in 14 HIV+COPD+, 13 HIV+COPD-, and 7 HIV-COPD+ individuals. Measurements and Main Results: HIV+COPD+ individuals demonstrated profound CD4+ T-cell depletion with reduced CD4/CD8 T-cell ratios in bronchoalveolar lavage-derived lung mononuclear cells, not observed in peripheral blood mononuclear cells, and diminished CD4+ T cell absolute numbers, compared with control subjects. Furthermore, HIV+COPD+ individuals demonstrated decreased pulmonary HIV-specific and staphylococcal enterotoxin B-reactive CD4+ memory responses, including loss of multifunctionality, compared with HIV+COPD- control subjects. In contrast, lung mucosal HIV-specific CD8+ T-cell responseswere preserved. LungCD4+ T cells from HIV+COPD+ individuals expressed increased surface Fas death receptor (CD95) and programmed death-1, but similar bronchoalveolar lavage viral loads as control subjects. However, programmed death-1 expression inversely correlated with HIV-specific lung CD4+IFN-γ+ T-cell responses, suggesting functional exhaustion. Moreover, lung CD41 T cells from HIV+COPD+ patients demonstrated increased basal and HIV antigen-induced expression of the early apoptosis marker annexin V compared with control subjects, which was significantly attenuated with anti-Fas blockade. Lastly, lung mucosal, but not blood, CD4+/CD8+ ratios from HIV+ patients significantly correlated with the FEV+, but not in HIV-COPD+ patients. Conclusions: Together, our results provide evidence for profound lung mucosal CD4+ T-cell depletion via a Fas-dependent activationinduced cell death mechanism, along with impaired HIV-specific CD4+ immunity as immunologic features of HIV-associated COPD.
KW - Apoptosis
KW - COPD
KW - HIV
KW - Immune activation
KW - T cells
UR - http://www.scopus.com/inward/record.url?scp=84928404850&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928404850&partnerID=8YFLogxK
U2 - 10.1164/rccm.201407-1226OC
DO - 10.1164/rccm.201407-1226OC
M3 - Article
C2 - 25137293
AN - SCOPUS:84928404850
SN - 1073-449X
VL - 190
SP - 744
EP - 755
JO - American journal of respiratory and critical care medicine
JF - American journal of respiratory and critical care medicine
IS - 7
ER -